000 01674nam a2200409 i 4500
999 _c272743
_d272743
001 on1041933869
003 OCoLC
005 20180731154305.0
006 m o d f
007 cr bn||||a||||
008 180626m20189999dcu o f000 0 eng c
040 _aPUCPR
_beng
_erda
_epn
_cGPO
_dMvI
042 _apcc
043 _an-us---
074 _a1008-I (online)
086 0 _aY 1.1/8:115-760/
099 _aY 1.1/8:115-760/
110 1 _aUnited States.
_bCongress.
_bHouse.
_bCommittee on Ways and Means,
245 1 0 _aExpanding Oversight of Opioid Prescribing and Payment Act of 2018 :
_breport (to accompany H.R. 5723) (including cost estimate of the Congressional Budget Office).
264 1 _a[Washington, D.C.] :
_b[U.S. Government Publishing Office],
_c[2018]-
300 _a1 online resource (volumes).
336 _btxt
337 _bc
_2rdamedia
338 _bcr
_2rdacarrier
490 1 _aReport / 115th Congress, 2d session, House of Representatives ;
_v115-760
500 _a"June 19, 2018"--Pt. 1.
500 _aCRDP Program record.
588 _aDescription based on online resource; title from part 1 PDF title screen (govinfo web site, viewed on June 26, 2018).
810 1 _aUnited States.
_bCongress.
_bHouse.
_tReport ;
_v115-760.
856 4 0 _uhttp://purl.fdlp.gov/GPO/gpo94095
050 4 _aKF32
_b.W3 2018g
610 2 0 _aMedicare Payment Advisory Commission (U.S.)
_xRules and practice.
650 0 _aOpioid abuse
_zUnited States
_xPrevention.
650 0 _aDrugs
_xPrescribing
_xLaw and legislation
_zUnited States.
655 7 _aLegislative materials.
_2lcgft
942 _2sudocs
_c8